Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
Mais filtros

Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Nutr Neurosci ; 23(6): 411-421, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-30126346

RESUMO

Introduction: Obesity promotes hypothalamic inflammation and local morphological changes in astrocytes, including the increased expression of the astrocytic biomarker glial fibrillary acidic protein (GFAP), which is seen as a sign of neuroinflammation.Objective: This study aimed to observe the astrocytic expression of GFAP in different brain areas from female rats that received a hypercaloric (HD) or a normocaloric (ND) diet during puberty (F0 generation) as well as in their male pups (F1 generation).Methods: Female rats received highly palatable HD (Ensure®) or ND from postnatal day (PND) 23-65. On PND90-95, some were euthanized for the immunohistochemical study and some were mated to obtain the F1 generation. Male pups were immunochallenged on PND50 with lipopolysaccharide (LPS, 100 µg/kg) or 0.9% saline solution (1 mL/kg) intraperitoneal injection. Body weight (BW) and retroperitoneal fat weight (RFW) were recorded on PND95 for F0 generation and on PND50 for F1 generation. GFAP expression for both generations was assessed by morphometry in the parietal/frontal cortex, corpus callosum, nucleus accumbens, arcuate/periventricular nuclei of hypothalamus, pons, molecular/granular layers of cerebellum.Results: Female rats fed with HD presented a significant increase in the GFAP expression in all evaluated areas as well as in the RFW. Male rats born from mothers that received HD showed decreased GFAP expression, BW and RFW when treated with LPS in relation to those from mothers fed with ND.Discussion: HD induced astrogliosis in several brain areas in females from F0 generation and an adaptive phenotypic change of decreased GFAP expression in males from F1 generation after LPS challenge.


Assuntos
Astrócitos/metabolismo , Encéfalo/metabolismo , Proteína Glial Fibrilar Ácida/metabolismo , Obesidade/metabolismo , Animais , Encefalite/metabolismo , Ingestão de Energia , Feminino , Gliose/metabolismo , Lipopolissacarídeos , Masculino , Ratos Wistar
2.
J Zoo Wildl Med ; 45(2): 213-8, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-25000680

RESUMO

Fibropapillomatosis continues to be an important cause of morbidity and mortality in sea turtles, particularly in Chelonia mydas. Turtles with this debilitating herpesvirus disease usually present with multiple, large, and ulcerated cutaneous masses that compromise both locomotion and feeding. There are very few available therapeutic strategies, with surgical excision being the most common. However, this surgical excision is associated with a high rate of local disease recurrence and secondary infections. Electrochemotherapy has been used for the treatment of epithelial neoplasm in several animal species. This technique is based on a combination of chemotherapy, usually with bleomycin or cisplatin, and electroporation. It consists of a series of short, high-voltage electric pulses that lead to increased membrane permeability and more efficient transport of antineoplastic drugs through the cellular membrane. Here, two C. mydas fibropapillomas were treated with a standard electrochemotherapy protocol using intralesional bleomycin sulfate injections followed by the application of electric pulses. Two sessions were performed, with a 33-day interval between sessions. Complete regression of lesions occurred without side effects or complications in each animal. There was no sign of local recurrence, even 1 yr after the end of treatment. Electrochemotherapy may be an effective therapeutic alternative for sea turtles with fibropapillomas.


Assuntos
Antibióticos Antineoplásicos/uso terapêutico , Bleomicina/uso terapêutico , Eletroquimioterapia/veterinária , Papiloma/terapia , Tartarugas , Animais , Antibióticos Antineoplásicos/administração & dosagem , Bleomicina/administração & dosagem , Eletroquimioterapia/métodos
3.
Arq Neuropsiquiatr ; 77(9): 601-608, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31553389

RESUMO

OBJECTIVE: Hypothalamic inflammation and glial fibrillary acidic protein (GFAP) overexpression in astrocytes are well described in obese animals, as are some cognitive and memory deficits. As the hippocampus plays important roles in the consolidation of information, this investigation aimed to observe the memory function and the astrocyte expression of GFAP in the hippocampus of rats that received either a hypercaloric or a normocaloric diet. METHODS: Adult male Wistar rats received a high-fat (cafeteria) or a standard diet for 60 days. On the 61st day, the rats were submitted to the novel object recognition (NOR) test at three and 24 hours after the first contact with objects, to assess short-term and long-term memory, respectively. Thereafter, the rats were euthanized and their brains were collected for GFAP immunohistochemical investigation in the hippocampus (CA1, CA2, CA3 areas) and hypothalamus (periventricular and arcuate nuclei). Astrocytic reactivity was assessed by morphometry. Different white adipose tissue depots and brown adipose tissue were weighed to calculate the adiposity index. RESULTS: The hypercaloric diet increased body weight gain, adiposity index, white adipose tissue weight (epididymal, subcutaneous and retroperitoneal) and brown adipose tissue weight. Rats fed with the hypercaloric diet showed short-term and long-term memory impairments in the NOR test, as well as increased GFAP expression in astrocytes from all analyzed hypothalamic and hippocampal areas. CONCLUSION: This astrogliosis suggests that the neuroinflammatory response also occurs in the hippocampus and may be involved in the memory losses observed in obese/overweight animals.


Assuntos
Astrócitos/química , Dieta Hiperlipídica/efeitos adversos , Proteína Glial Fibrilar Ácida/análise , Hipocampo/citologia , Transtornos da Memória/etiologia , Obesidade/complicações , Tecido Adiposo/metabolismo , Animais , Proteína Glial Fibrilar Ácida/metabolismo , Imuno-Histoquímica , Masculino , Transtornos da Memória/metabolismo , Obesidade/metabolismo , Ratos Wistar , Valores de Referência , Fatores de Tempo
4.
Arq Neuropsiquiatr ; 76(4): 252-256, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29742238

RESUMO

Obesity is associated with a chronic and low-grade inflammatory response in the hypothalamus, where astrogliosis occurs with the upregulation of the astrocyte structural protein GFAP. As propentofylline (PPF) has inhibitory effects on astrocyte and microglial activation during inflammation, this study aimed to investigate if this xanthine derivative could decrease the astrocyte reaction induced by a hypercaloric diet (HD). Male Wistar rats were divided into four groups: NDS - rats receiving a normocaloric diet (ND) and daily saline solution; NDP - rats receiving ND and daily PPF (12.5 mg/kg/day, intraperitoneal route); HDS - rats receiving HD and saline solution, HDP - rats receiving HD and PPF. On the 21st day, rats were anesthetized, and perfused, and brains were collected for GFAP immunohistochemical study in the hypothalamus. Results showed that HD induced increased weight gain and hypothalamic astrogliosis. Propentofylline decreased the expression of GFAP in the HDP group, although it did not affect the weight gain induced by this diet.


Assuntos
Dieta Hiperlipídica/efeitos adversos , Proteína Glial Fibrilar Ácida/análise , Gliose/etiologia , Doenças Hipotalâmicas/etiologia , Xantinas/administração & dosagem , Animais , Gliose/prevenção & controle , Doenças Hipotalâmicas/prevenção & controle , Masculino , Ratos , Ratos Wistar
5.
Arq Neuropsiquiatr ; 74(9): 730-736, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27706422

RESUMO

OBJECTIVE: This study aimed to evaluate the effect of propentofylline administration on astrocytic response following gliotoxic injury. METHOD: Wistar rats were injected with ethidium bromide into the cisterna pontis and treated or not with propentofylline (12.5mg/kg/day, intraperitoneal) during the experimental period. Brainstem sections were collected from 15 to 31 days after gliotoxic injection and processed for GFAP immunohistochemistry. RESULTS AND CONCLUSION: Results demonstrate that propentofylline decreased astrocytic activation until the 21st day, suggesting that this drug may have a role in reducing glial scar development following injury.


Assuntos
Astrócitos/efeitos dos fármacos , Tronco Encefálico/efeitos dos fármacos , Fármacos Neuroprotetores/farmacologia , Xantinas/farmacologia , Animais , Astrócitos/metabolismo , Tronco Encefálico/metabolismo , Doenças Desmielinizantes/metabolismo , Doenças Desmielinizantes/prevenção & controle , Modelos Animais de Doenças , Etídio/toxicidade , Proteína Glial Fibrilar Ácida/análise , Proteína Glial Fibrilar Ácida/efeitos dos fármacos , Gliotoxina/toxicidade , Imuno-Histoquímica , Masculino , Ratos Wistar , Reprodutibilidade dos Testes , Fatores de Tempo , Resultado do Tratamento
6.
Arch Endocrinol Metab ; 59(1): 47-53, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25926114

RESUMO

OBJECTIVE: The diabetic state induced by streptozotocin injection is known to impair oligodendroglial remyelination in the rat brainstem following intracisternal injection with the gliotoxic agent ethidium bromide (EB). In such experimental model, propentofylline (PPF) recently showed to improve myelin repair, probably due to its neuroprotective, antiinflammatory and antioxidant effects. The aim of this study was to evaluate the effect of PPF administration in diabetic rats submitted to the EB-demyelinating model. MATERIALS AND METHODS: Adult male rats, diabetic or not, received a single injection of 10 microlitres of 0.1% EB solution into the cisterna pontis. For induction of diabetes mellitus the streptozotocin-diabetogenic model was used (50 mg/kg, intraperitoneal route - IP). Some diabetic rats were treated with PPF (12.5 mg/kg/day, IP route) during the experimental period. The animals were anesthetized and perfused from 7 to 31 days after EB injection and brainstem sections were collected for analysis of the lesions by light and transmission electron microscopy. RESULTS: Diabetic rats injected with EB showed larger amounts of myelin-derived membranes in the central areas of the lesions and considerable delay in the remyelinating process played by surviving oligodendrocytes and invading Schwann cells after the 15th day. On the other hand, diabetic rats that received PPF presented lesions similar to those of non-diabetic animals, with rapid remyelination at the edges of the lesion site and fast clearance of myelin debris from the central area. CONCLUSION: The administration of PPF apparently reversed the impairment in remyelination induced by the diabetic state.


Assuntos
Astrócitos/efeitos dos fármacos , Doenças Desmielinizantes/tratamento farmacológico , Diabetes Mellitus Experimental/tratamento farmacológico , Bainha de Mielina/fisiologia , Fármacos Neuroprotetores/farmacologia , Xantinas/farmacologia , Animais , Doenças Desmielinizantes/patologia , Diabetes Mellitus Experimental/induzido quimicamente , Modelos Animais de Doenças , Etídio/toxicidade , Macrófagos/efeitos dos fármacos , Masculino , Mesencéfalo/patologia , Microscopia Eletrônica de Transmissão , Regeneração Nervosa/efeitos dos fármacos , Fármacos Neuroprotetores/administração & dosagem , Ponte/patologia , Ratos Wistar , Células de Schwann/efeitos dos fármacos , Estreptozocina , Xantinas/administração & dosagem
7.
Arq. neuropsiquiatr ; Arq. neuropsiquiatr;77(9): 601-608, Sept. 2019. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1038743

RESUMO

ABSTRACT Objective: Hypothalamic inflammation and glial fibrillary acidic protein (GFAP) overexpression in astrocytes are well described in obese animals, as are some cognitive and memory deficits. As the hippocampus plays important roles in the consolidation of information, this investigation aimed to observe the memory function and the astrocyte expression of GFAP in the hippocampus of rats that received either a hypercaloric or a normocaloric diet. Methods: Adult male Wistar rats received a high-fat (cafeteria) or a standard diet for 60 days. On the 61st day, the rats were submitted to the novel object recognition (NOR) test at three and 24 hours after the first contact with objects, to assess short-term and long-term memory, respectively. Thereafter, the rats were euthanized and their brains were collected for GFAP immunohistochemical investigation in the hippocampus (CA1, CA2, CA3 areas) and hypothalamus (periventricular and arcuate nuclei). Astrocytic reactivity was assessed by morphometry. Different white adipose tissue depots and brown adipose tissue were weighed to calculate the adiposity index. Results: The hypercaloric diet increased body weight gain, adiposity index, white adipose tissue weight (epididymal, subcutaneous and retroperitoneal) and brown adipose tissue weight. Rats fed with the hypercaloric diet showed short-term and long-term memory impairments in the NOR test, as well as increased GFAP expression in astrocytes from all analyzed hypothalamic and hippocampal areas. Conclusion: This astrogliosis suggests that the neuroinflammatory response also occurs in the hippocampus and may be involved in the memory losses observed in obese/overweight animals.


RESUMO Objetivo: A inflamação hipotalâmica e a superexpressão da proteína glial fibrilar ácida (GFAP) em astrócitos são bem descritas em animais obesos, assim como déficits cognitivos e de memória. Como o hipocampo desempenha importante papel na consolidação de informações, esta investigação teve como objetivo observar a função da memória e a expressão astrocitária da GFAP no hipocampo de ratos que receberam dieta hipercalórica ou normocalórica. Métodos: Ratos Wistar machos adultos receberam dieta rica em gordura (cafeteria) ou dieta padrão por 60 dias. No 61º dia, os ratos foram submetidos ao teste de reconhecimento de objetos (NOR) 3 e 24 horas após o primeiro contato com os objetos, para avaliação da memória de curto e de longo prazo, respectivamente. Após, os ratos foram eutanasiados e os encéfalos coletados para pesquisa imuno-histoquímica da expressão astrocitária de GFAP no hipocampo (áreas CA1, CA2 e CA3) e no hipotálamo (núcleos periventricular e arqueado). A reatividade astrocitária foi avaliada por morfometria. Diferentes depósitos de tecido adiposo branco e marrom foram pesados para calcular o índice de adiposidade. Resultados: A dieta hipercalórica aumentou o ganho de peso corporal, o índice de adiposidade, o peso do tecido adiposo branco (epididimal, subcutâneo e retroperitoneal) e marrom. Ratos alimentados com dieta hipercalórica apresentaram prejuízos na memória de curto e longo prazo no teste NOR e aumento da expressão de GFAP em astrócitos de todas as áreas hipotalâmicas e hipocampais analisadas. Conclusão: Esta astrogliose sugere que a resposta neuroinflamatória também ocorre no hipocampo, podendo estar envolvida nas perdas de memória observadas em animais obesos/com sobrepeso.


Assuntos
Animais , Masculino , Astrócitos/química , Dieta Hiperlipídica/efeitos adversos , Proteína Glial Fibrilar Ácida/análise , Hipocampo/citologia , Transtornos da Memória/etiologia , Obesidade/complicações , Valores de Referência , Fatores de Tempo , Imuno-Histoquímica , Tecido Adiposo/metabolismo , Ratos Wistar , Proteína Glial Fibrilar Ácida/metabolismo , Transtornos da Memória/metabolismo , Obesidade/metabolismo
8.
Microsc Res Tech ; 77(1): 23-30, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24185688

RESUMO

Propentofylline (PPF) is a xanthine derivative with pharmacological effects distinct from those of the classical methylxanthines. It depresses activation of microglial cells and astrocytes which is associated with neuronal damage during neural inflammation and hypoxia. The aim of this study was to evaluate whether PPF had the capacity of affecting glial cells behavior during the process of demyelination and remyelination following ethidium bromide (EB) gliotoxic injury. EB injection into the CNS is commonly used as an experimental demyelinating model inducing local oligodendroglial and astrocytic death, which results in primary demyelination, blood-brain barrier and glia limitans disruption and Schwann cells invasion. Sixty Wistar rats were divided into four different groups receiving 10 microlitres of 0.1% EB or 0.9% saline solution into the cisterna pontis and treated or not with the xanthine. PPF treatment was done using 12.5 mg/kg/day by the intraperitonial route for 31 days of the experimental period. The rats were euthanized from 7 to 31 days after EB injection and brainstem sections were collected and processed for light and transmission electron microscopy studies. Results from both groups were compared by using a semi-quantitative method developed for documenting in semithin sections the extent and nature of remyelination of demyelinating lesions. Results showed that PPF administration after EB injection significantly increased both oligodendroglial and Schwann cell remyelination at 31 days (mean remyelination scores of 3.67 ± 0.5 for oligodendrocytes and 1.27 ± 0.49 for Schwann cells) compared to untreated animals (scores of 3.19 ± 0.57 and 0.90 ± 0.33, respectively).


Assuntos
Tronco Encefálico/efeitos dos fármacos , Doenças Desmielinizantes/tratamento farmacológico , Xantinas/administração & dosagem , Animais , Tronco Encefálico/metabolismo , Doenças Desmielinizantes/metabolismo , Modelos Animais de Doenças , Humanos , Masculino , Bainha de Mielina/metabolismo , Oligodendroglia/efeitos dos fármacos , Oligodendroglia/metabolismo , Ratos , Ratos Wistar , Células de Schwann/efeitos dos fármacos , Células de Schwann/metabolismo
9.
Arq Bras Endocrinol Metabol ; 57(6): 431-6, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24030182

RESUMO

OBJECTIVE: The aim of this study was to evaluate the effect of diabetic hyperglycemia on astrocyte function, estimated by means of glial fibrillary acidic protein - GFAP - immunohistochemical expression. MATERIALS AND METHODS: Adult male rats received a single intravenous injection of streptozotocin (50 mg/kg) and were submitted 10 days later to a single injection of 10 microlitres 0.1% EB solution or 0.9% saline solution into the cisterna pontis. Ten microliters of 0.1% EB or 0.9% saline solution were also injected in non-diabetic rats. Animals were anesthetized and perfused through the heart 15 and 31 days after EB or saline injection, and brainstem sections were collected for ultrastructural analysis and GFAP immunohistochemical staining. RESULTS: The GFAP brown-stained areas were evaluated by colorimetry using a computerized image analysis system and the results have shown that diabetes hindered the increase of GFAP astrocyte expression in the EB-injected group compared to non-diabetic animals. However, diabetes did not affect GFAP response in the saline-injected group or in control animals. CONCLUSION: Streptozotocin-induced diabetic condition reduced astrocytic GFAP expression following gliotoxic injury.


Assuntos
Astrócitos/metabolismo , Glicemia/metabolismo , Tronco Encefálico/patologia , Diabetes Mellitus Experimental/patologia , Proteína Glial Fibrilar Ácida/metabolismo , Adulto , Animais , Tronco Encefálico/efeitos dos fármacos , Modelos Animais de Doenças , Etídio/toxicidade , Proteína Glial Fibrilar Ácida/efeitos adversos , Humanos , Imuno-Histoquímica , Masculino , Ratos , Ratos Wistar , Estreptozocina
10.
Arq. neuropsiquiatr ; Arq. neuropsiquiatr;76(4): 252-256, Apr. 2018. graf
Artigo em Inglês | LILACS | ID: biblio-888375

RESUMO

ABSTRACT Obesity is associated with a chronic and low-grade inflammatory response in the hypothalamus, where astrogliosis occurs with the upregulation of the astrocyte structural protein GFAP. As propentofylline (PPF) has inhibitory effects on astrocyte and microglial activation during inflammation, this study aimed to investigate if this xanthine derivative could decrease the astrocyte reaction induced by a hypercaloric diet (HD). Male Wistar rats were divided into four groups: NDS - rats receiving a normocaloric diet (ND) and daily saline solution; NDP - rats receiving ND and daily PPF (12.5 mg/kg/day, intraperitoneal route); HDS - rats receiving HD and saline solution, HDP - rats receiving HD and PPF. On the 21st day, rats were anesthetized, and perfused, and brains were collected for GFAP immunohistochemical study in the hypothalamus. Results showed that HD induced increased weight gain and hypothalamic astrogliosis. Propentofylline decreased the expression of GFAP in the HDP group, although it did not affect the weight gain induced by this diet.


RESUMO A obesidade está associada com uma resposta inflamatória crônica e de baixo grau no hipotálamo, onde ocorre astrogliose com a superexpressão da proteína astrocitária GFAP. Como a propentofilina (PPF) possui efeitos inibitórios sobre a ativação astrocitária e microglial durante a inflamação, este estudo visou a investigar se esta xantina podia diminuir a reação astrocitária induzida pela dieta hipercalórica (HD). Ratos Wistar machos foram divididos em 4 grupos: NDS- ratos recebendo dieta normocalórica (ND) e solução salina diária; NDP- ratos recebendo ND e PPF diária (12.5 mg/kg/dia, via intraperitoneal); HDS- ratos recebendo HD e solução salina, HDP- ratos recebendo HD e PPF. No 21° dia, os ratos foram perfundidos e os encéfalos, coletados para estudo imuno-histoquímico para a GFAP no hipotálamo. Os resultados mostram que a HD induziu aumento do ganho de peso e astrogliose no hipotálamo. A PPF diminuiu a expressão de GFAP no grupo HD, embora não tenha afetado o ganho de peso induzido por esta dieta.


Assuntos
Animais , Masculino , Ratos , Xantinas/administração & dosagem , Dieta Hiperlipídica/efeitos adversos , Proteína Glial Fibrilar Ácida/análise , Gliose/etiologia , Doenças Hipotalâmicas/etiologia , Ratos Wistar , Gliose/prevenção & controle , Doenças Hipotalâmicas/prevenção & controle
11.
Arq Neuropsiquiatr ; 70(3): 221-5, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22392117

RESUMO

Ethidium bromide (EB) causes local astrocytic disappearance, with glia limitans disruption and blood-brain barrier (BBB) breakdown. The aim of this study was to evaluate the BBB integrity after the injection of 0.1% EB or 0.9% saline solution into the cisterna pontis of Wistar rats submitted or not to the streptozotocin diabetogenic model. Brainstem sections were collected from 24 hours to 31 days post-injection for ultrastructural analysis and glial fibrillary acidic protein immunohistochemical staining. Some animals received colloidal carbon ink by intravenous route at the same periods. In rats injected with EB, results revealed astrocyte disappearance and leakage of carbon particles beginning at 48 hours and persisting for 7 days in non-diabetic rats and for 15 days in the diabetic ones, although, in both groups, several areas remained devoid of astrocytic processes up to 31 days. In rats injected with saline, there was no sign of astrocytic loss or carbon particles leakage.


Assuntos
Barreira Hematoencefálica/efeitos dos fármacos , Tronco Encefálico/efeitos dos fármacos , Diabetes Mellitus Experimental/patologia , Etídio/farmacologia , Proteína Glial Fibrilar Ácida/química , Cloreto de Sódio/farmacologia , Animais , Barreira Hematoencefálica/metabolismo , Barreira Hematoencefálica/patologia , Tronco Encefálico/patologia , Imuno-Histoquímica , Masculino , Ratos , Ratos Wistar , Estreptozocina
12.
Arq Neuropsiquiatr ; 69(2B): 377-83, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21625769

RESUMO

The use of cyclosporine (CsA) has shown to induce an increase in the density of oligodendrocytes near remyelinating areas following the injection of ethidium bromide (EB), a demyelinating agent, in the rat brainstem. This study was designed in order to evaluate if CsA has the capacity of increasing remyelination. In this context, a comparison between the final balance of myelin repair in CsA treated and non-treated rats was assessed using a semi-quantitative method developed for documenting the extent and nature of remyelination in gliotoxic lesions. Wistar rats were submitted to intracisternal injection of 10 microliters of 0.1% EB. Some were treated during 31 days with CsA (group III--10 mg/kg/day by 7 days and, thereafter, 3 times a week, with a minimal interval of 48 hours) by intraperitonial route. Others were not treated with CsA (group I). A control group was planned receiving into the cisterna pontis 10 microliters of 0.9% saline solution and following after that the same CsA administration protocol (group II). Results clearly demonstrate that in vivo administration of CsA after EB-demyelinating lesions stimulated oligodendrocyte remyelination (mean remyelination scores of 3.72±0.25 for oligodendrocytes and 1.04±0.39 for Schwann cells) compared to non-treated animals (3.13±0.71 and 1.31±0.62, respectively), although the mechanisms by which this positive CsA effect occurs are unclear.


Assuntos
Ciclosporina/uso terapêutico , Doenças Desmielinizantes/tratamento farmacológico , Imunossupressores/uso terapêutico , Bainha de Mielina/efeitos dos fármacos , Regeneração Nervosa/efeitos dos fármacos , Oligodendroglia/efeitos dos fármacos , Animais , Tronco Encefálico/efeitos dos fármacos , Doenças Desmielinizantes/induzido quimicamente , Doenças Desmielinizantes/patologia , Modelos Animais de Doenças , Etídio , Bainha de Mielina/fisiologia , Ratos , Ratos Wistar , Fatores de Tempo
13.
Arq. neuropsiquiatr ; Arq. neuropsiquiatr;74(9): 730-736, Sept. 2016. tab, graf
Artigo em Inglês | LILACS | ID: lil-796044

RESUMO

ABSTRACT Propentofylline is a xanthine derivative that depresses activation of glial cells, whose responses contribute to neural tissue damage during inflammation. Ethidium bromide injection into the central nervous system induces local oligodendroglial and astrocytic loss, resulting in primary demyelination, neuroinflammation and blood-brain barrier disruption. Surviving astrocytes present a vigorous reaction around the injury site with increased immunoreactivity to glial fibrillary acidic protein (GFAP). Objective This study aimed to evaluate the effect of propentofylline administration on astrocytic response following gliotoxic injury. Method Wistar rats were injected with ethidium bromide into the cisterna pontis and treated or not with propentofylline (12.5mg/kg/day, intraperitoneal) during the experimental period. Brainstem sections were collected from 15 to 31 days after gliotoxic injection and processed for GFAP immunohistochemistry. Results and Conclusion Results demonstrate that propentofylline decreased astrocytic activation until the 21st day, suggesting that this drug may have a role in reducing glial scar development following injury.


RESUMO A propentofilina é uma xantina que deprime a ativação das células gliais, cujas respostas contribuem para o dano neural durante inflamação. A injeção de brometo de etídio no sistema nervoso central induz a perda oligodendroglial e astrocitária, resultando em desmielinização, neuroinflamação e ruptura da barreira hematoencefálica. Os astrócitos sobreviventes apresentam vigorosa reação ao redor da lesão com aumento da imunorreatividade à proteína glial fibrilar ácida (GFAP). Objetivo Este estudo objetivou avaliar o efeito da propentofilina sobre a resposta astrocitária após injúria gliotóxica. Método Ratos Wistar foram injetados com brometo de etídio na cisterna basal e tratados ou não com propentofilina (12.5mg/kg/dia, intraperitoneal). Amostras do tronco encefálico foram coletadas dos 15 aos 31 dias pós-injeção do gliotóxico e processadas para estudo ultraestrutural e imuno-histoquímico para GFAP. Resultados e Conclusão Os resultados demonstram que a propentofilina reduziu a ativação astrocitária até o 21o dia, sugerindo que essa droga pode atuar na redução da cicatriz glial após injúria.


Assuntos
Animais , Masculino , Xantinas/farmacologia , Tronco Encefálico/efeitos dos fármacos , Astrócitos/efeitos dos fármacos , Fármacos Neuroprotetores/farmacologia , Fatores de Tempo , Tronco Encefálico/metabolismo , Imuno-Histoquímica , Astrócitos/metabolismo , Reprodutibilidade dos Testes , Doenças Desmielinizantes/metabolismo , Doenças Desmielinizantes/prevenção & controle , Resultado do Tratamento , Ratos Wistar , Modelos Animais de Doenças , Etídio/toxicidade , Proteína Glial Fibrilar Ácida/análise , Proteína Glial Fibrilar Ácida/efeitos dos fármacos , Gliotoxina/toxicidade
14.
Braz. j. pharm. sci ; 52(4): 623-633, Oct.-Dec. 2016. graf
Artigo em Inglês | LILACS | ID: biblio-951871

RESUMO

ABSTRACT Pro-inflammatory cytokines and glial cells, especially microglial cells, have been implicated in persistent pain sensitization. Less is known about the role of astrocytes in pain regulation. This study aimed to observe the expression of the astrocytic biomarker glial fibrillary acidic protein (GFAP) and the serum levels of interleukin 1 beta (IL-1ß) and tumor necrosis factor alpha (TNF-α) after short-term administration of central pain relievers in rats not submitted to noxious stimuli. Male Wistar rats were divided into five groups, receiving for nine days- (1) amitriptyline (Amt-10 mg/kg/day, by gavage); (2) gabapentin (Gb-60 mg/kg/day, by gavage; (3) methadone (Me-4.5 mg/kg/day, intraperitoneal route [IP]); (4) morphine (Mo-10 mg/kg/day, IP); or (5) 0.9% saline solution, IP. Brain samples were collected for immunohistochemical study of GFAP expression in the mesencephalon and nucleus accumbens (NAc). The area of GFAP-positive cells was calculated using MetaMorph software and serum levels of IL-1ß and TNF-α were measured by enzyme-linked immunosorbent assay. Serum TNF-α levels were decreased in the groups treated with Mo, Me and Gb, but not in the Amt-treated group. IL-1ß decreased only in rats treated with Me. The astrocytic expression of GFAP was decreased in the brainstem with all drugs, while it was increased in the NAc with Amt, Me and Mo


Assuntos
Animais , Masculino , Ratos , Proteína Glial Fibrilar Ácida/análise , Analgésicos/farmacologia , Dor/tratamento farmacológico , Astrócitos/imunologia , Citocinas/classificação
15.
Arch. endocrinol. metab. (Online) ; 59(1): 47-53, 02/2015. tab, graf
Artigo em Inglês | LILACS | ID: lil-746451

RESUMO

Objective The diabetic state induced by streptozotocin injection is known to impair oligodendroglial remyelination in the rat brainstem following intracisternal injection with the gliotoxic agent ethidium bromide (EB). In such experimental model, propentofylline (PPF) recently showed to improve myelin repair, probably due to its neuroprotective, antiinflammatory and antioxidant effects. The aim of this study was to evaluate the effect of PPF administration in diabetic rats submitted to the EB-demyelinating model. Materials and methods Adult male rats, diabetic or not, received a single injection of 10 microlitres of 0.1% EB solution into the cisterna pontis. For induction of diabetes mellitus the streptozotocin-diabetogenic model was used (50 mg/kg, intraperitoneal route – IP). Some diabetic rats were treated with PPF (12.5 mg/kg/day, IP route) during the experimental period. The animals were anesthetized and perfused from 7 to 31 days after EB injection and brainstem sections were collected for analysis of the lesions by light and transmission electron microscopy. Results Diabetic rats injected with EB showed larger amounts of myelin-derived membranes in the central areas of the lesions and considerable delay in the remyelinating process played by surviving oligodendrocytes and invading Schwann cells after the 15th day. On the other hand, diabetic rats that received PPF presented lesions similar to those of non-diabetic animals, with rapid remyelination at the edges of the lesion site and fast clearance of myelin debris from the central area. Conclusion The administration of PPF apparently reversed the impairment in remyelination induced by the diabetic state. Arch Endocrinol Metab. 2015;59(1):47-53 .


Assuntos
Animais , Masculino , Astrócitos/efeitos dos fármacos , Doenças Desmielinizantes/tratamento farmacológico , Diabetes Mellitus Experimental/tratamento farmacológico , Bainha de Mielina/fisiologia , Fármacos Neuroprotetores/farmacologia , Xantinas/farmacologia , Modelos Animais de Doenças , Doenças Desmielinizantes/patologia , Diabetes Mellitus Experimental/induzido quimicamente , Etídio/toxicidade , Microscopia Eletrônica de Transmissão , Macrófagos/efeitos dos fármacos , Mesencéfalo/patologia , Regeneração Nervosa/efeitos dos fármacos , Fármacos Neuroprotetores/administração & dosagem , Ponte/patologia , Ratos Wistar , Estreptozocina , Células de Schwann/efeitos dos fármacos , Xantinas/administração & dosagem
16.
Arq Neuropsiquiatr ; 68(5): 783-7, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21049194

RESUMO

Schwann cells are recognized by their capacity of producing single internodes of myelin around axons of the peripheral nervous system. In the ethidium bromide (EB) model of primary demyelination in the brainstem, it is observed the entry of Schwann cells into the central nervous system in order to contribute to the myelin repair performed by the oligodendrocytes that survived to the EB gliotoxic action, being able to even remyelinate more than one axon at the same time, in a pattern of repair similar to the oligodendroglial one. The present study was developed in the spinal cord to observe if Schwann cells maintained this competence of attending simultaneously different internodes. It was noted that, on the contrary of the brainstem, Schwann cells were the most important myelinogenic cells in the demyelinated site and, although rare, also presented the capacity of producing more than one internode of myelin in distinct axons.


Assuntos
Bainha de Mielina/fisiologia , Regeneração Nervosa/fisiologia , Oligodendroglia/fisiologia , Células de Schwann/fisiologia , Medula Espinal/citologia , Animais , Diferenciação Celular/efeitos dos fármacos , Diferenciação Celular/fisiologia , Etídio/farmacologia , Masculino , Bainha de Mielina/efeitos dos fármacos , Oligodendroglia/efeitos dos fármacos , Ratos , Ratos Wistar , Células de Schwann/efeitos dos fármacos , Medula Espinal/efeitos dos fármacos , Fatores de Tempo
17.
Arq. bras. endocrinol. metab ; Arq. bras. endocrinol. metab;57(6): 431-436, ago. 2013. ilus, tab
Artigo em Inglês | LILACS | ID: lil-685404

RESUMO

OBJECTIVE: The aim of this study was to evaluate the effect of diabetic hyperglycemia on astrocyte function, estimated by means of glial fibrillary acidic protein - GFAP - immunohistochemical expression. MATERIALS AND METHODS: Adult male rats received a single intravenous injection of streptozotocin (50 mg/kg) and were submitted 10 days later to a single injection of 10 microlitres 0.1% EB solution or 0.9% saline solution into the cisterna pontis. Ten microliters of 0.1% EB or 0.9% saline solution were also injected in non-diabetic rats. Animals were anesthetized and perfused through the heart 15 and 31 days after EB or saline injection, and brainstem sections were collected for ultrastructural analysis and GFAP immunohistochemical staining. RESULTS: The GFAP brown-stained areas were evaluated by colorimetry using a computerized image analysis system and the results have shown that diabetes hindered the increase of GFAP astrocyte expression in the EB-injected group compared to non-diabetic animals. However, diabetes did not affect GFAP response in the saline-injected group or in control animals. CONCLUSION: Streptozotocin-induced diabetic condition reduced astrocytic GFAP expression following gliotoxic injury.


OBJETIVO: O objetivo deste estudo foi avaliar o efeito da hiperglicemia na função astrocitária, estimada pela expressão imuno-histoquímica da proteína glial fibrilar ácida - GFAP. MATERIAIS E MÉTODOS: Ratos machos adultos receberam uma injeção intravenosa única de estreptozotocina (50 mg/kg) e foram submetidos, 10 dias após, à injeção de 10 microlitros de solução de BE 0,1% ou de salina 0,9% na cisterna pontina. Dez microlitros de BE 0,1% ou salina 0,9% foram também injetados em ratos não diabéticos. Os animais foram anestesiados e perfundidos por via intracardíaca aos 15 e 31 dias pós-injeção de BE ou salina, e amostras de tronco encefálico foram coletadas para estudo ultraestrutural e análise imuno-histoquímica para a GFAP. RESULTADOS: Utilizando um sistema computadorizado de análise de imagens, os resultados das áreas coradas em marrom pela GFAP, medidas por colorimetria, mostram que o diabetes reduziu o aumento de expressão dessa proteína no grupo injetado com BE em comparação aos animais não diabéticos, mas não alterou a resposta no grupo injetado com salina ou nos controles diabéticos. CONCLUSÃO: O estado diabético induzido pela estreptozotocina reduziu a expressão astrocitária de GFAP após dano gliotóxico.


Assuntos
Adulto , Animais , Humanos , Masculino , Ratos , Astrócitos/metabolismo , Glicemia/metabolismo , Tronco Encefálico/patologia , Diabetes Mellitus Experimental/patologia , Proteína Glial Fibrilar Ácida/metabolismo , Tronco Encefálico/efeitos dos fármacos , Modelos Animais de Doenças , Etídio/toxicidade , Proteína Glial Fibrilar Ácida/efeitos adversos , Imuno-Histoquímica , Ratos Wistar , Estreptozocina
18.
Arq. neuropsiquiatr ; Arq. neuropsiquiatr;70(3): 221-225, Mar. 2012. ilus
Artigo em Inglês | LILACS | ID: lil-616908

RESUMO

Ethidium bromide (EB) causes local astrocytic disappearance, with glia limitans disruption and blood-brain barrier (BBB) breakdown. The aim of this study was to evaluate the BBB integrity after the injection of 0.1 percent EB or 0.9 percent saline solution into the cisterna pontis of Wistar rats submitted or not to the streptozotocin diabetogenic model. Brainstem sections were collected from 24 hours to 31 days post-injection for ultrastructural analysis and glial fibrillary acidic protein immunohistochemical staining. Some animals received colloidal carbon ink by intravenous route at the same periods. In rats injected with EB, results revealed astrocyte disappearance and leakage of carbon particles beginning at 48 hours and persisting for 7 days in non-diabetic rats and for 15 days in the diabetic ones, although, in both groups, several areas remained devoid of astrocytic processes up to 31 days. In rats injected with saline, there was no sign of astrocytic loss or carbon particles leakage.


O brometo de etídio (BE) determina o desaparecimento local de astrócitos, com ruptura da glia limitans e dano na barreira hematoencefálica (BHE). Este estudo visou avaliar a integridade da BHE após injeção de solução de BE a 0,1 por cento ou de salina a 0,9 por cento na cisterna pontis de ratos Wistar submetidos ou não ao modelo diabetogênico da estreptozotocina. Fragmentos do tronco encefálico foram coletados das 24 horas aos 31 dias pós-injeção para estudo ultraestrutural e marcação imuno-histoquímica para proteína glial fibrilar ácida. Alguns animais receberam carvão coloidal por via intravenosa nos mesmos períodos. Nos grupos injetados com BE, os resultados mostraram desaparecimento astrocitário e extravasamento de partículas de carvão nas lesões a partir das 48 horas, persistindo por até sete dias nos animais não diabéticos e 15 dias nos diabéticos, embora, em ambos os grupos, diversas áreas permanecessem destituídas de astrócitos até 31 dias após. Nos ratos injetados com salina, diabéticos ou não, não houve sinal de perda astrocitária nem de extravasamento vascular de carvão.


Assuntos
Animais , Masculino , Ratos , Barreira Hematoencefálica/efeitos dos fármacos , Tronco Encefálico/efeitos dos fármacos , Diabetes Mellitus Experimental/patologia , Etídio/farmacologia , Proteína Glial Fibrilar Ácida/química , Cloreto de Sódio/farmacologia , Barreira Hematoencefálica/metabolismo , Barreira Hematoencefálica/patologia , Tronco Encefálico/patologia , Imuno-Histoquímica , Ratos Wistar , Estreptozocina
19.
Ciênc. rural ; Ciênc. rural (Online);42(12): 2229-2234, dez. 2012. tab
Artigo em Português | LILACS | ID: lil-658035

RESUMO

Este estudo teve como objetivo verificar a eficiência do uso de imunoestimulante associado a anti-helmíntico no tratamento das helmintoses de ovinos. Os animais do grupo I (n=29) receberam o anti-helmíntico albendazole (11mg kg-1) em administração única e o imunoestimulante composto de Propionibacterium granulosum (16ug kg-1) e lipopolissacarídeo (LPS) de Escherichia coli (1,2ug kg-1) em duas doses com intervalo de 48 horas e os animais do grupo II (n=29) receberam o anti-helmíntico albendazole (11mg kg-1). Amostras foram colhidas semanalmente durante 28 dias para a realização da contagem total e diferencial de leucócitos, hematócrito e contagem de ovos por grama de fezes (OPG). Os animais que receberam imunoestimulante associado a anti-helmíntico apresentaram aumento significativo dos valores de eosinófilos e linfócitos (P<0,05) em relação aos animais que receberam somente anti-helmíntico. Na contagem de ovos por grama de fezes (OPG), não foram observadas diferenças significativas entre os grupos (P>0,05). Com base nesses resultados, pode-se concluir que imunoestimulantes podem ser utilizados associados a anti-helmínticos como alternativa terapêutica no tratamento das helmintíases em ovinos, uma vez que promovem a ativação da resposta imune com participação de células e mediadores importantes para a eliminação de helmintos em ovinos.


This study aimed to verify the effectiveness of the immunostimulant combined with anthelmintic on the helminthiasis treatment in sheep. The animals of group I (n=29) received the anthelmintic albendazole (11mg kg-1) in a single administration and the immunostimulant composed with Propionibacterium granulosum (16ug kg-1) and lypopolysaccharide (LPS) of Escherichia coli (1,2ug kg-1) into two doses every 48 hours and the animals from group II (n=29) received anthelmintic albendazole (11mg g-1). Samples were collected weekly during 28 days, to carry out the total and differential count of leukocytes, hematocrit and the eggs count per gram of feces (EPG). The animals that received immunostimulant combined with anthelmintic showed significantly increases of eosinophils and lymphocytes (P<0.05) compared to animals that only received the anthelmintic. In eggs count per gram of feces (EPG), there were no significant differences between groups (P>0.05). Based on these results it was concluded that immunostimulants can be used when combined with anthelminthic as an alternative therapy for the treatment of helminthiasis in sheep, since they promote the activation of immune response with participation of cells and mediators important for the removal of helminths in sheep.

20.
Arq. neuropsiquiatr ; Arq. neuropsiquiatr;68(5): 783-787, Oct. 2010. ilus
Artigo em Inglês | LILACS | ID: lil-562809

RESUMO

Schwann cells are recognized by their capacity of producing single internodes of myelin around axons of the peripheral nervous system. In the ethidium bromide (EB) model of primary demyelination in the brainstem, it is observed the entry of Schwann cells into the central nervous system in order to contribute to the myelin repair performed by the oligodendrocytes that survived to the EB gliotoxic action, being able to even remyelinate more than one axon at the same time, in a pattern of repair similar to the oligodendroglial one. The present study was developed in the spinal cord to observe if Schwann cells maintained this competence of attending simultaneously different internodes. It was noted that, on the contrary of the brainstem, Schwann cells were the most important myelinogenic cells in the demyelinated site and, although rare, also presented the capacity of producing more than one internode of myelin in distinct axons.


As células de Schwann são reconhecidas por sua capacidade de produzir internodos de mielina únicos ao redor de axônios do sistema nervoso periférico. No modelo de desmielinização primária do brometo de etídio (BE) no tronco encefálico, tem sido observada a entrada destas células no sistema nervoso central. Isso pode contribuir para o reparo mielínico desempenhado pelos oligodendrócitos que sobreviveram à ação glitóxica do BE, chegando a remielinizar mais de um axônio ao mesmo tempo, em um padrão de reparo semelhante ao oligodendroglial. O presente estudo foi realizado na medula espinhal para observar se as células de Schwann mantinham esta competência de atender simultaneamente diferentes internodos. Foi observado que, ao contrário do tronco encefálico, as células de Schwann foram as células mielinogênicas mais importantes no sítio de desmielinização induzida pelo BE e, embora raro, também apresentaram a capacidade de produzir mais de um internodo de mielina em axônios distintos.


Assuntos
Animais , Masculino , Ratos , Bainha de Mielina/fisiologia , Regeneração Nervosa/fisiologia , Oligodendroglia/fisiologia , Células de Schwann/fisiologia , Medula Espinal/citologia , Diferenciação Celular/efeitos dos fármacos , Diferenciação Celular/fisiologia , Etídio/farmacologia , Bainha de Mielina/efeitos dos fármacos , Oligodendroglia/efeitos dos fármacos , Ratos Wistar , Células de Schwann/efeitos dos fármacos , Medula Espinal/efeitos dos fármacos , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA